What might change sentiment is the FDA giving us a break on the ridiculous red tape.
Favipiravir, used in real world settings totalling zero, has undertaken a phase 2 trial similar to Lani and is now undertaking two Phase 3 trials totaling 1,200 patients. Fair enough.
Lani, used 9 million times in real world settings, is expected to follow the same trials as Favipiravir.
Simply ridiculous.
- Forums
- ASX - By Stock
- BTA
- tamiflu potential dud?
tamiflu potential dud?, page-6
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)